These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8571688

  • 1. [Gestagens and breast diseases].
    Lober R.
    Zentralbl Gynakol; 1995; 117 Suppl():19-24. PubMed ID: 8571688
    [No Abstract] [Full Text] [Related]

  • 2. [Gestagens and hormone substitution].
    Klinger G.
    Zentralbl Gynakol; 1995; 117 Suppl():25-9. PubMed ID: 8571690
    [No Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR.
    Cancer; 2003 Oct 01; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract] [Full Text] [Related]

  • 4. [Biologic bases of the treatment of diffuse benign breast diseases].
    Van Bogaert LJ.
    J Gynecol Obstet Biol Reprod (Paris); 1976 Jun 01; 5(4):567-75. PubMed ID: 783246
    [Abstract] [Full Text] [Related]

  • 5. Mastalgia.
    Preece PE.
    Practitioner; 1982 Aug 01; 226(1370):1373-82. PubMed ID: 7134151
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical studies with synthetic gestagens].
    Tóth F, Horn B, Primász P.
    Orv Hetil; 1969 Jul 27; 110(30):1723-7. PubMed ID: 5801101
    [No Abstract] [Full Text] [Related]

  • 7. NHLBI stops trial of estrogen plus progestin due to increased breast cancer risk and lack of overall benefit.
    South Med J; 2002 Aug 27; 95(8):795-7. PubMed ID: 12190211
    [No Abstract] [Full Text] [Related]

  • 8. [Gestagens and corpus luteum insufficiency].
    Rothe K.
    Zentralbl Gynakol; 1995 Aug 27; 117 Suppl():2-5. PubMed ID: 8571689
    [No Abstract] [Full Text] [Related]

  • 9. [Benign diseases of the breast. Therapeutic aspects].
    Marzetti L, Framarino Dei Malatesta ML.
    Minerva Ginecol; 1982 Nov 27; 34(11):883-8. PubMed ID: 7155413
    [No Abstract] [Full Text] [Related]

  • 10. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
    von Schoultz B, Bergkvist L, Magnusson C, von Schoultz E.
    Lakartidningen; 2000 May 03; 97(18):2225-6. PubMed ID: 10850053
    [No Abstract] [Full Text] [Related]

  • 11. Role of progestins in the premenopausal climacteric.
    Schindler AE.
    Gynecol Endocrinol; 1999 Dec 03; 13 Suppl 6():35-40. PubMed ID: 10862267
    [Abstract] [Full Text] [Related]

  • 12. The role of progestin therapy in breast disease and central nervous system function.
    Lobo RA, Gibbons WE.
    J Reprod Med; 1982 Aug 03; 27(8 Suppl):515-21. PubMed ID: 6813466
    [No Abstract] [Full Text] [Related]

  • 13. [Skin allergies after treatment with steroidal sex hormones].
    Herschberg AD, Canu M.
    Gynecologie; 1976 Aug 03; 27(1):53-6. PubMed ID: 133040
    [No Abstract] [Full Text] [Related]

  • 14. Progestagen-only treatment before menopause: increased risk of breast cancer.
    Prescrire Int; 2008 Dec 03; 17(98):243. PubMed ID: 19422175
    [Abstract] [Full Text] [Related]

  • 15. HRT 2000: pause for thought.
    Harv Womens Health Watch; 2000 Apr 03; 7(8):1-3. PubMed ID: 10712769
    [No Abstract] [Full Text] [Related]

  • 16. Differential effects of various progestogens on metabolic risk factors for breast cancer.
    Campagnoli C, Abbà C, Ambroggio S, Lotano MR, Peris C.
    Gynecol Endocrinol; 2007 Oct 03; 23 Suppl 1():22-31. PubMed ID: 17943536
    [Abstract] [Full Text] [Related]

  • 17. [Hormone treatment of benign breast diseases].
    Mauvais-Jarvis P.
    Bull Cancer; 1991 Oct 03; 78(4):365-71. PubMed ID: 1859904
    [No Abstract] [Full Text] [Related]

  • 18. [Steroid hormones and ovarian carcinoma].
    Slotman BJ, Rao BR.
    Ned Tijdschr Geneeskd; 1989 Oct 14; 133(41):2017-9. PubMed ID: 2677802
    [No Abstract] [Full Text] [Related]

  • 19. Progestins and breast cancer risk.
    Campagnoli C, Biglia N, Giai M, Sismondi P.
    Zentralbl Gynakol; 1997 Oct 14; 119 Suppl 2():38-42. PubMed ID: 9361393
    [Abstract] [Full Text] [Related]

  • 20. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW, MacLennan AH.
    Climacteric; 2003 Sep 14; 6(3):177-9. PubMed ID: 14567764
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.